BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25234005)

  • 21. Design, synthesis and biological evaluation of cinnamic acyl shikonin derivatives.
    Lin HY; Chen W; Shi J; Kong WY; Qi JL; Wang XM; Yang YH
    Chem Biol Drug Des; 2013 Feb; 81(2):275-83. PubMed ID: 23066914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reaction of beta-alkannin (shikonin) with reactive oxygen species: detection of beta-alkannin free radicals.
    Gao D; Kakuma M; Oka S; Sugino K; Sakurai H
    Bioorg Med Chem; 2000 Nov; 8(11):2561-9. PubMed ID: 11092541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and human telomeric G-quadruplex DNA-binding activity of glucosaminosides of shikonin/alkannin.
    He H; Bai LP; Jiang ZH
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1582-6. PubMed ID: 22281188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Shikonin and its derivatives: a patent review.
    Wang R; Yin R; Zhou W; Xu D; Li S
    Expert Opin Ther Pat; 2012 Sep; 22(9):977-97. PubMed ID: 22834677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Studies on CD spectra of derivatives of shikonin and alkannin].
    Ai KH; Jin J; Liu H
    Yao Xue Xue Bao; 1993; 28(4):282-5. PubMed ID: 8213171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (E) -6-(1-alkyloxyiminoalkyl)-5,8-dimethoxy-1,4-naphthoquinones: synthesis, cytotoxic activity and antitumor activity.
    You YJ; Kim Y; Song GY; Ahn BZ
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2301-3. PubMed ID: 11055343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumor activity of DMAKO-05, a novel shikonin derivative, and its metabolism in rat liver microsome.
    Zhang X; Wang RB; Zhou W; Xiao S; Meng QQ; Li SS
    AAPS PharmSciTech; 2015 Apr; 16(2):259-66. PubMed ID: 25273027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and synthesis of fluoroacylshikonin as an anticancer agent.
    Kong WY; Chen XF; Shi J; Baloch SK; Qi JL; Zhu HL; Wang XM; Yang YH
    Chirality; 2013 Nov; 25(11):757-62. PubMed ID: 23908135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biological activity of novel shikonin analogues.
    Wang W; Dai M; Zhu C; Zhang J; Lin L; Ding J; Duan W
    Bioorg Med Chem Lett; 2009 Feb; 19(3):735-7. PubMed ID: 19111464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological evaluation of novel pyrrolo[2,1-c][1,4]benzodiazepine prodrugs for use in antibody-directed enzyme prodrug therapy.
    Masterson LA; Spanswick VJ; Hartley JA; Begent RH; Howard PW; Thurston DE
    Bioorg Med Chem Lett; 2006 Jan; 16(2):252-6. PubMed ID: 16290933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel N-oxide of naphthalimides as prodrug leads against hypoxic solid tumor: synthesis and biological evaluation.
    Yin H; Xu Y; Qian X; Li Y; Liu J
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2166-70. PubMed ID: 17331719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemically stable, lipophilic prodrugs of phosphoramide mustard as potential anticancer agents.
    Kwon CH; Moon KY; Baturay N; Shirota FN
    J Med Chem; 1991 Feb; 34(2):588-92. PubMed ID: 1995881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Shikonin time-dependently induced necrosis or apoptosis in gastric cancer cells via generation of reactive oxygen species.
    Lee MJ; Kao SH; Hunag JE; Sheu GT; Yeh CW; Hseu YC; Wang CJ; Hsu LS
    Chem Biol Interact; 2014 Mar; 211():44-53. PubMed ID: 24463199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved synthesis of N-benzylaminoferrocene-based prodrugs and evaluation of their toxicity and antileukemic activity.
    Daum S; Chekhun VF; Todor IN; Lukianova NY; Shvets YV; Sellner L; Putzker K; Lewis J; Zenz T; de Graaf IA; Groothuis GM; Casini A; Zozulia O; Hampel F; Mokhir A
    J Med Chem; 2015 Feb; 58(4):2015-24. PubMed ID: 25633601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel cyclopropapyrroloindole derivative (AT-3510) bearing methoxycarbonyl and trifluoromethyl groups.
    Fukuda Y; Furuta H; Kusama Y; Ebisu H; Oomori Y; Terashima S
    J Med Chem; 1999 Apr; 42(8):1448-58. PubMed ID: 10212131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antitumor effect research progress of shikonin and its derivatives].
    Zhu MY; Wang RB; Zhou W; Li SS
    Yao Xue Xue Bao; 2012 May; 47(5):588-93. PubMed ID: 22812000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aziridinyldinitrobenzamides: synthesis and structure-activity relationships for activation by E. coli nitroreductase.
    Helsby NA; Atwell GJ; Yang S; Palmer BD; Anderson RF; Pullen SM; Ferry DM; Hogg A; Wilson WR; Denny WA
    J Med Chem; 2004 Jun; 47(12):3295-307. PubMed ID: 15163209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of novel aminoquinonoid analogues of diospyrin and evaluation of their inhibitory activity against murine and human cancer cells.
    Das Sarma M; Ghosh R; Patra A; Hazra B
    Eur J Med Chem; 2008 Sep; 43(9):1878-88. PubMed ID: 18281125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Synthesis and anticancer activity of norcantharidin-galactose derivatives].
    Fan F; Sun XF
    Yao Xue Xue Bao; 2008 Feb; 43(2):157-61. PubMed ID: 18507342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and preclinical characterization of a paclitaxel prodrug with improved antitumor activity and water solubility.
    Niethammer A; Gaedicke G; Lode HN; Wrasidlo W
    Bioconjug Chem; 2001; 12(3):414-20. PubMed ID: 11353540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.